invasive Meningococcal Disease caused by Neisseria meningitidis serogroup C
invasive Meningococcal Disease caused by Neisseria meningitidis serogroup C is the indication for 5 drugs in DrugBank. It is covered by 6 curated, structured indications.
- Also known as
- invasive Meningococcal Infection caused by Neisseria meningitidis serogroup C · Invasive Infection caused by Neisseria meningitidis serogroup C
- Classified under
- Indicated drugs
- Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine
- Meningococcal polysaccharide vaccine group C
- Neisseria meningitidis group A capsular polysaccharide tetanus toxoid conjugate antigen
- Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen
- Neisseria meningitidis group C capsular polysaccharide tetanus toxoid conjugate antigen
What you can answer from here — as of October 25, 2026
5Indicated drugsWith each drug's targets and mechanismListed above
6Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for invasive Meningococcal Disease caused by Neisseria meningitidis serogroup C share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account